Author:
Challa Sri Sai Subramanyam,Chawda Abhip Dilip,Benke Abhishek Pandurang,Tilala Mitul
Abstract
Change control is a critical component of regulatory affairs in various industries, particularly in pharmaceuticals, medical devices, and biotechnology. This research paper explores the challenges associated with traditional change control processes and presents best practices for streamlining these processes to improve efficiency, compliance, and overall product quality. Through a comprehensive literature review and analysis of case studies from leading organizations, we identify key strategies for optimizing change control workflows, leveraging technology, and fostering a culture of continuous improvement. The paper also examines the impact of streamlined change control processes on regulatory compliance, product lifecycle management, and organizational performance. Our findings suggest that implementing these best practices can lead to significant reductions in change implementation time, improved regulatory compliance, and enhanced product quality and safety.
Reference55 articles.
1. International Conference on Harmonisation. (2000). Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. ICH Harmonised Tripartite Guideline.
2. Ramnarine, E., & O'Donnell, K. (2018). Establishing a Change Control System: Ensuring Pharmaceutical Quality. PDA Journal of Pharmaceutical Science and Technology, 72(3), 339-349.
3. Chatten, R., & Chatten, J. (2019). Managing Pharmaceutical Quality: A Practical Guide. CRC Press.
4. Gough, A., & Naylor, R. (2020). Streamlining Change Control in Pharmaceutical Manufacturing. Pharmaceutical Engineering, 40(3), 50-55.
5. FDA. (2022). Guidance for Industry: Changes to an Approved NDA or ANDA. U.S. Food and Drug Administration.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Implementing Predictive Analytics for Proactive Revenue Cycle Management;Journal for Research in Applied Sciences and Biotechnology;2024-08-26